Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NECROPTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NECROPTOSIS is a concept in neurodegeneration research. Key relationships include: associated with, activates, co discussed. Associated with ALS, ALZHEIMER'S DISEASE, CANCER. Connected to 80 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | NECROPTOSIS |
| Key Genes/Proteins | ACHE, AD, ALS, AMYLOID |
| Related Diseases | AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
| Related Pathways | APOPTOSIS, APOPTOSIS PATHWAY |
Knowledge base pages for this entity
flowchart TD
Necroptosis["Necroptosis"]
Als["Als"]
Cancer["Cancer"]
APOPTOSIS(["APOPTOSIS"])
INFLAMMATION(["INFLAMMATION"])
PYROPTOSIS(["PYROPTOSIS"])
FERROPTOSIS(["FERROPTOSIS"])
CANCER(["CANCER"])
RIPK3(["RIPK3"])
MLKL(["MLKL"])
Tumor["Tumor"]
Inflammation["Inflammation"]
AUTOPHAGY(["AUTOPHAGY"])
Als -->|"activates"| Necroptosis
Cancer -->|"therapeutic target"| Necroptosis
Als -->|"therapeutic target"| Necroptosis
APOPTOSIS -->|"regulates"| Necroptosis
INFLAMMATION -->|"activates"| Necroptosis
PYROPTOSIS -->|"regulates"| Necroptosis
FERROPTOSIS -->|"regulates"| Necroptosis
APOPTOSIS -->|"activates"| Necroptosis
CANCER -->|"therapeutic target"| Necroptosis
RIPK3 -->|"regulates"| Necroptosis
MLKL -->|"regulates"| Necroptosis
Cancer -->|"activates"| Necroptosis
Tumor -->|"activates"| Necroptosis
Inflammation -->|"activates"| Necroptosis
AUTOPHAGY -->|"regulates"| Necroptosis
style Necroptosis fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Neuronal Loss | causes | phenotype | 0.95 |
| ALZHEIMER'S DISEASE | causes | disease | 0.95 |
| Neurodegeneration | mediates | process | 0.95 |
| Neurodegeneration | causes | process | 0.95 |
| Cell Death | component_of | process | 0.95 |
| Cell Death | involved_in | process | 0.95 |
| astrocyte | causes | cell_type | 0.95 |
| Regulated Cell Death | component_of | process | 0.95 |
| Programmed Cell Death | involved_in | process | 0.90 |
| Alzheimer'S Disease | involved_in | disease | 0.90 |
| ALZHEIMER'S DISEASE | involved_in | disease | 0.90 |
| Neuroinflammation | contributes_to | process | 0.90 |
| Pulmonary Arterial Endothelial Cells | involved_in | cell_type | 0.90 |
| neural stem cells | active_in | cell_type | 0.90 |
| Alzheimer's Disease | involved_in | disease | 0.90 |
| Granulovacuolar Degeneration | associated_with | phenotype | 0.90 |
| pyroptosis | crosstalk_with | pathway | 0.90 |
| Proinflammatory Mediators | causes | process | 0.90 |
| neurons | active_in | cell_type | 0.90 |
| Proinflammatory Mediator Production | causes | process | 0.90 |
| Antitumor Immunity | associated_with | process | 0.90 |
| antitumor immunity | promotes | process | 0.90 |
| TAU | associated_with | protein | 0.90 |
| Tau Pathology | correlates_with | biomarker | 0.90 |
| alzheimer_disease | implicated_in | disease | 0.90 |
| Granulovacuolar Neurodegeneration | involved_in | process | 0.90 |
| Endothelial Cell Dysfunction | contributes_to | phenotype | 0.90 |
| Neurodegenerative Diseases | involved_in | disease | 0.90 |
| Sepsis-Associated Acute Kidney Injury | involved_in | disease | 0.85 |
| Inflammation | associated_with | process | 0.85 |
| Chronic Kidney Disease | contributes_to | disease | 0.85 |
| Damage-Associated Molecular Patterns | associated_with | biomarker | 0.85 |
| Alzheimer's Disease | contributes_to | disease | 0.85 |
| Multiple sclerosis | contributes_to | disease | 0.85 |
| hippocampal sclerosis | contributes_to | phenotype | 0.85 |
| Age-Dependent Neuroinflammatory Diseases | risk_factor_for | disease | 0.85 |
| PRO-INFLAMMATORY CYTOKINES | produces | protein | 0.85 |
| Neurodegeneration | contributes_to | process | 0.85 |
| Neurodegenerative Diseases | contributes_to | disease | 0.85 |
| proinflammatory mediators | upregulates | compound | 0.85 |
| tumor immunogenicity | associated_with | phenotype | 0.85 |
| Alzheimer's Disease | contributes_to | disease | 0.85 |
| Axonal Degeneration | associated_with | process | 0.85 |
| Proinflammatory Mediators | associated_with | biomarker | 0.85 |
| Axonal Degeneration | causes | phenotype | 0.85 |
| Endo-Lysosomal Pathway | interacts_with | pathway | 0.80 |
| Chronic Kidney Disease | drives | disease | 0.80 |
| Parkinson's Disease | associated_with | disease | 0.80 |
| microglia | active_in | cell_type | 0.80 |
| Parkinson's disease | contributes_to | disease | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | regulates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| FERROPTOSIS | regulates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| PYROPTOSIS | regulates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| RIPK3 | regulates | gene | 1.00 |
| MLKL | regulates | gene | 1.00 |
| RIPK3 | component_of | gene | 0.95 |
| RIPK1 | component_of | gene | 0.95 |
| PRKAA1 | inhibits | gene | 0.95 |
| Tnf-Α/Nf-Κb/Mapk Signaling Pathway | mediates | pathway | 0.95 |
| Compound 1F | associated_with | compound | 0.95 |
| Metformin | suppresses | drug | 0.95 |
| compound 1f | associated_with | compound | 0.95 |
| PANoptosis | involved_in | process | 0.95 |
| RIPK3 | mediates | protein | 0.95 |
| MLKL | mediates | protein | 0.95 |
| PANoptosis | component_of | process | 0.95 |
| RIPK1 | mediates | protein | 0.95 |
| RIPK1/RIPK3 Signaling Cascade | regulates | pathway | 0.95 |
| Ponicidin | inhibits | compound | 0.92 |
| HSYA | suppresses | compound | 0.92 |
| Alzheimer's disease | involves | disease | 0.90 |
| RIPK1 | participates_in | gene | 0.90 |
| MLKL | participates_in | gene | 0.90 |
| RIPK3 | associated_with | protein | 0.90 |
| ALS | participates_in | gene | 0.90 |
| Cadmium | drives | compound | 0.90 |
| 40075110 | was activated in | paper | 0.90 |
| 34857917 | is dispensable for | paper | 0.90 |
| RIPK3 | participates_in | gene | 0.90 |
| Valproic Acid | inhibits | drug | 0.90 |
| TNF | participates_in | gene | 0.90 |
| RIP3 | mediates | protein | 0.90 |
| TNF receptor | activates | receptor | 0.90 |
| PARP5A | inhibits | protein | 0.90 |
| apoptosis pathway | crosstalk_with | pathway | 0.90 |
| RNF146 | inhibits | protein | 0.90 |
| cGAS/STING pathway | activates | pathway | 0.90 |
| apoptosis pathway | mediates | pathway | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology | 0.460 | neuroinflammation | How does chronic cGAS/STING activation d |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning NECROPTOSIS in their description or question text
No additional research found